Bristol-Myers Squibb Comapny
Records under this name other than the patents Bristol-Myers Squibb Comapny holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Bristol-Myers Squibb Comapny
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,432,267 | Fused cyclic modulators of nuclear hormone receptor function Term ended Term ended Jun 25, 2022 · USPTO record | Term ended | Term ended Jun 25, 2022 | USPTO record |
| US 10,308,702 | BSL2v2c2-Ig polypeptides Held by another company Term ended Term ended Dec 5, 2021 · Medium confidence | Term ended | Term ended Dec 5, 2021 | Medium confidence |